![]() |
Miracll Chemicals Co., Ltd (300848.sz) Valoración de DCF
CN | Basic Materials | Chemicals - Specialty | SHZ
|

- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Miracll Chemicals Co.,Ltd (300848.SZ) Bundle
¡Descubra el verdadero potencial de MiraCll Chemicals Co., Ltd con nuestra calculadora DCF avanzada! Ajuste los supuestos clave, explore varios escenarios y evalúe cómo los diferentes factores afectan a MiraCll Chemicals Co., Valoración de LTD, todo dentro de una plantilla de Excel conveniente.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 648.5 | 756.9 | 1,297.8 | 1,475.1 | 1,475.1 | 1,850.7 | 2,321.9 | 2,913.1 | 3,654.7 | 4,585.2 |
Revenue Growth, % | 0 | 16.71 | 71.47 | 13.66 | 0.00556064 | 25.46 | 25.46 | 25.46 | 25.46 | 25.46 |
EBITDA | 109.5 | 134.4 | 158.3 | 144.6 | 129.9 | 242.3 | 304.0 | 381.3 | 478.4 | 600.2 |
EBITDA, % | 16.89 | 17.75 | 12.2 | 9.8 | 8.81 | 13.09 | 13.09 | 13.09 | 13.09 | 13.09 |
Depreciation | 13.5 | 17.4 | 22.6 | 26.6 | 29.4 | 36.8 | 46.1 | 57.9 | 72.6 | 91.1 |
Depreciation, % | 2.08 | 2.3 | 1.74 | 1.81 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 |
EBIT | 96.0 | 116.9 | 135.7 | 118.0 | 100.5 | 205.5 | 257.8 | 323.5 | 405.8 | 509.2 |
EBIT, % | 14.81 | 15.45 | 10.46 | 8 | 6.81 | 11.1 | 11.1 | 11.1 | 11.1 | 11.1 |
Total Cash | 154.2 | 538.2 | 827.2 | 680.2 | 920.5 | 988.8 | 1,240.6 | 1,556.4 | 1,952.7 | 2,449.9 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 39.6 | 53.4 | 95.5 | 148.8 | 266.3 | 180.1 | 226.0 | 283.5 | 355.7 | 446.2 |
Account Receivables, % | 6.1 | 7.06 | 7.36 | 10.09 | 18.05 | 9.73 | 9.73 | 9.73 | 9.73 | 9.73 |
Inventories | 60.1 | 94.6 | 342.2 | 257.5 | 315.4 | 321.9 | 403.8 | 506.7 | 635.7 | 797.5 |
Inventories, % | 9.27 | 12.5 | 26.37 | 17.45 | 21.38 | 17.39 | 17.39 | 17.39 | 17.39 | 17.39 |
Accounts Payable | 161.8 | 196.7 | 633.5 | 83.8 | 873.0 | 609.3 | 764.4 | 959.0 | 1,203.2 | 1,509.5 |
Accounts Payable, % | 24.94 | 25.99 | 48.81 | 5.68 | 59.18 | 32.92 | 32.92 | 32.92 | 32.92 | 32.92 |
Capital Expenditure | -27.1 | -26.6 | -202.0 | -372.6 | -786.3 | -376.9 | -472.8 | -593.2 | -744.3 | -933.7 |
Capital Expenditure, % | -4.18 | -3.51 | -15.57 | -25.26 | -53.31 | -20.36 | -20.36 | -20.36 | -20.36 | -20.36 |
Tax Rate, % | 2.11 | 2.11 | 2.11 | 2.11 | 2.11 | 2.11 | 2.11 | 2.11 | 2.11 | 2.11 |
EBITAT | 83.6 | 102.7 | 123.5 | 118.0 | 98.4 | 190.6 | 239.2 | 300.1 | 376.5 | 472.3 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | 132.1 | 80.1 | 91.3 | -746.2 | -44.7 | -333.6 | -160.2 | -201.0 | -252.2 | -316.4 |
WACC, % | 6.19 | 6.19 | 6.21 | 6.24 | 6.23 | 6.21 | 6.21 | 6.21 | 6.21 | 6.21 |
PV UFCF | ||||||||||
SUM PV UFCF | -1,056.2 | |||||||||
Long Term Growth Rate, % | 4.00 | |||||||||
Free cash flow (T + 1) | -329 | |||||||||
Terminal Value | -14,880 | |||||||||
Present Terminal Value | -11,009 | |||||||||
Enterprise Value | -12,065 | |||||||||
Net Debt | -211 | |||||||||
Equity Value | -11,854 | |||||||||
Diluted Shares Outstanding, MM | 394 | |||||||||
Equity Value Per Share | -30.10 |
Benefits You Will Receive
- Authentic MC Financial Data: Access comprehensive historical and projected data for precise valuation.
- Customizable Parameters: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Real-Time Calculations: Intrinsic value and NPV are computed automatically.
- Scenario Exploration: Evaluate various scenarios to assess the future performance of Miracll Chemicals Co., Ltd (300848SZ).
- User-Friendly Interface: Designed for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive Historical Data: Pre-loaded with Miracll Chemicals' (300848SZ) past financial performance and future projections.
- Customizable Parameters: Modify factors such as revenue growth, profit margins, discount rates, tax rates, and capital investments.
- Adaptive Valuation Framework: Automatic recalculations of Net Present Value (NPV) and intrinsic value according to your specified inputs.
- Scenario Analysis Capability: Develop various forecasting scenarios to evaluate different valuation results.
- Intuitive Interface: Designed for ease of use, making it accessible for both professionals and novices.
How It Works
- Step 1: Download the Excel file for Miracll Chemicals Co., Ltd (300848SZ).
- Step 2: Review the pre-filled financial data and forecasts for Miracll Chemicals.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify the assumptions.
- Step 5: Analyze the results and leverage the outputs for informed investment decisions.
Why Opt for Miracll Chemicals Co., Ltd's Calculator?
- Time-Efficient: Skip the hassle of building a DCF model from the ground up – it's pre-configured for immediate use.
- Enhanced Precision: Dependable financial data and calculations minimize valuation errors.
- Completely Customizable: Adjust the model to align with your specific assumptions and forecasts.
- User-Friendly Visuals: Intuitive charts and outputs simplify the analysis of results.
- Endorsed by Industry Professionals: Crafted for experts who prioritize accuracy and practicality.
Who Should Utilize This Product?
- Individual Investors: Gain insights to make informed decisions regarding shares of Miracll Chemicals Co., Ltd (300848SZ).
- Financial Analysts: Enhance valuation processes with accessible financial models tailored for Miracll Chemicals Co., Ltd (300848SZ).
- Consultants: Provide clients with accurate and timely valuation insights related to Miracll Chemicals Co., Ltd (300848SZ).
- Business Owners: Learn from the valuation strategies of established companies like Miracll Chemicals Co., Ltd (300848SZ) to inform your own business approach.
- Finance Students: Explore valuation methodologies using real-world examples and data centred around Miracll Chemicals Co., Ltd (300848SZ).
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for Miracll Chemicals Co., Ltd (300848SZ), including metrics such as revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A specific sheet dedicated to the Weighted Average Cost of Capital (WACC), featuring parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models providing insights into intrinsic value, complete with thorough calculations.
- Financial Statements: Pre-loaded annual and quarterly financial statements to facilitate comprehensive analysis.
- Key Ratios: Details on profitability, leverage, and efficiency ratios specific to Miracll Chemicals Co., Ltd (300848SZ).
- Dashboard and Charts: A visual overview of valuation outputs and assumptions, designed for easy analysis of results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.